Hemogenyx Pharmaceuticals Plc Stock Net Asset
| HOPHF Stock | USD 0 0.00 0.00% |
Hemogenyx Pharmaceuticals Plc fundamentals help investors to digest information that contributes to Hemogenyx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Hemogenyx Pink Sheet. The fundamental analysis module provides a way to measure Hemogenyx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hemogenyx Pharmaceuticals pink sheet.
Hemogenyx |
Hemogenyx Pharmaceuticals Plc Company Net Asset Analysis
Hemogenyx Pharmaceuticals' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Hemogenyx Pharmaceuticals Net Asset | 8.52 M |
Most of Hemogenyx Pharmaceuticals' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hemogenyx Pharmaceuticals Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Hemogenyx Pharmaceuticals Plc has a Net Asset of 8.52 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net asset for all United States stocks is notably lower than that of the firm.
Hemogenyx Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hemogenyx Pharmaceuticals' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Hemogenyx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hemogenyx Pharmaceuticals by comparing valuation metrics of similar companies.Hemogenyx Pharmaceuticals is currently under evaluation in net asset category among its peers.
Hemogenyx Fundamentals
| Return On Equity | -0.32 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | 8.17 M | |||
| Shares Outstanding | 1.14 B | |||
| Shares Owned By Insiders | 13.01 % | |||
| Price To Book | 1.78 X | |||
| EBITDA | (2.39 M) | |||
| Net Income | (5.1 M) | |||
| Cash And Equivalents | 6.84 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 10.15 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 20.23 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (2.63 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 10 | |||
| Beta | 3.49 | |||
| Market Capitalization | 45.68 M | |||
| Total Asset | 8.52 M | |||
| Net Asset | 8.52 M |
About Hemogenyx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hemogenyx Pharmaceuticals Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemogenyx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemogenyx Pharmaceuticals Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Hemogenyx Pink Sheet
Hemogenyx Pharmaceuticals financial ratios help investors to determine whether Hemogenyx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemogenyx with respect to the benefits of owning Hemogenyx Pharmaceuticals security.